Fampridine for the improvement of walking in multiple sclerosis

Fampridine for the improvement of walking in multiple sclerosis

Fampridine (Fampyra) is a selective potassium channel blocker licensed for the improvement of walking in multiple sclerosis. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Ruth Dobson discusses its potential role in the treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Prescriber (London, England) England), 2012-04, Vol.23 (7), p.12-16
Hauptverfasser: Chaplin, Steve, Dobson, Ruth
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16
container_issue 7
container_start_page 12
container_title Prescriber (London, England)
container_volume 23
creator Chaplin, Steve
Dobson, Ruth
description Fampridine (Fampyra) is a selective potassium channel blocker licensed for the improvement of walking in multiple sclerosis. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Ruth Dobson discusses its potential role in the treatment of walking disability in multiple sclerosis. Copyright © 2012 Wiley Interface Ltd
doi_str_mv 10.1002/psb.890
format Article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_psb_890</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_FX40T6L3_G</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1770-ce16b78619be8d836ebf494b829aedd1bbcb470b6c6ac4f2e873f67e229db1343</originalsourceid><addsrcrecordid>eNp1z8tKw0AUBuBBFKxVfIXZuZDUuSRzWYmWtgpFBSu6G2aSMzo2l5KJ1r69kYg7VwcOH_85P0KnlEwoIexiE91EabKHRlRzmjCW8X00IjrTiRCKHaKjGN8JyTKRpSN0ObfVpg1FqAH7psXdG-DQb5pPqKDucOPx1pbrUL_iUOPqo-zCpgQc8xLaJoZ4jA68LSOc_M4xeprPVtObZHm_uJ1eLZOcSkmSHKhwUgmqHahCcQHOpzp1imkLRUGdy10qiRO5sHnqGSjJvZDAmC4c5Skfo7MhN-_Pxha86b-ubLszlJif3qbvbfrevTwf5DaUsPuPmYfH60Engw6xg68_bdu1EZLLzDzfLcz8JSUrseRmwb8BGqhpAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Fampridine for the improvement of walking in multiple sclerosis</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Chaplin, Steve ; Dobson, Ruth</creator><creatorcontrib>Chaplin, Steve ; Dobson, Ruth</creatorcontrib><description>Fampridine (Fampyra) is a selective potassium channel blocker licensed for the improvement of walking in multiple sclerosis. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Ruth Dobson discusses its potential role in the treatment of walking disability in multiple sclerosis. Copyright © 2012 Wiley Interface Ltd</description><identifier>ISSN: 0959-6682</identifier><identifier>EISSN: 1931-2253</identifier><identifier>DOI: 10.1002/psb.890</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><ispartof>Prescriber (London, England), 2012-04, Vol.23 (7), p.12-16</ispartof><rights>Copyright © 2012 Wiley Interface Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1770-ce16b78619be8d836ebf494b829aedd1bbcb470b6c6ac4f2e873f67e229db1343</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpsb.890$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpsb.890$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids></links><search><creatorcontrib>Chaplin, Steve</creatorcontrib><creatorcontrib>Dobson, Ruth</creatorcontrib><title>Fampridine for the improvement of walking in multiple sclerosis</title><title>Prescriber (London, England)</title><addtitle>Prescriber</addtitle><description>Fampridine (Fampyra) is a selective potassium channel blocker licensed for the improvement of walking in multiple sclerosis. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Ruth Dobson discusses its potential role in the treatment of walking disability in multiple sclerosis. Copyright © 2012 Wiley Interface Ltd</description><issn>0959-6682</issn><issn>1931-2253</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1z8tKw0AUBuBBFKxVfIXZuZDUuSRzWYmWtgpFBSu6G2aSMzo2l5KJ1r69kYg7VwcOH_85P0KnlEwoIexiE91EabKHRlRzmjCW8X00IjrTiRCKHaKjGN8JyTKRpSN0ObfVpg1FqAH7psXdG-DQb5pPqKDucOPx1pbrUL_iUOPqo-zCpgQc8xLaJoZ4jA68LSOc_M4xeprPVtObZHm_uJ1eLZOcSkmSHKhwUgmqHahCcQHOpzp1imkLRUGdy10qiRO5sHnqGSjJvZDAmC4c5Skfo7MhN-_Pxha86b-ubLszlJif3qbvbfrevTwf5DaUsPuPmYfH60Engw6xg68_bdu1EZLLzDzfLcz8JSUrseRmwb8BGqhpAg</recordid><startdate>20120405</startdate><enddate>20120405</enddate><creator>Chaplin, Steve</creator><creator>Dobson, Ruth</creator><general>John Wiley &amp; Sons, Ltd</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20120405</creationdate><title>Fampridine for the improvement of walking in multiple sclerosis</title><author>Chaplin, Steve ; Dobson, Ruth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1770-ce16b78619be8d836ebf494b829aedd1bbcb470b6c6ac4f2e873f67e229db1343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chaplin, Steve</creatorcontrib><creatorcontrib>Dobson, Ruth</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><jtitle>Prescriber (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chaplin, Steve</au><au>Dobson, Ruth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fampridine for the improvement of walking in multiple sclerosis</atitle><jtitle>Prescriber (London, England)</jtitle><addtitle>Prescriber</addtitle><date>2012-04-05</date><risdate>2012</risdate><volume>23</volume><issue>7</issue><spage>12</spage><epage>16</epage><pages>12-16</pages><issn>0959-6682</issn><eissn>1931-2253</eissn><abstract>Fampridine (Fampyra) is a selective potassium channel blocker licensed for the improvement of walking in multiple sclerosis. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Ruth Dobson discusses its potential role in the treatment of walking disability in multiple sclerosis. Copyright © 2012 Wiley Interface Ltd</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><doi>10.1002/psb.890</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-6682
ispartof Prescriber (London, England), 2012-04, Vol.23 (7), p.12-16
issn 0959-6682
1931-2253
language eng
recordid cdi_crossref_primary_10_1002_psb_890
source Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
title Fampridine for the improvement of walking in multiple sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T03%3A21%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fampridine%20for%20the%20improvement%20of%20walking%20in%20multiple%20sclerosis&rft.jtitle=Prescriber%20(London,%20England)&rft.au=Chaplin,%20Steve&rft.date=2012-04-05&rft.volume=23&rft.issue=7&rft.spage=12&rft.epage=16&rft.pages=12-16&rft.issn=0959-6682&rft.eissn=1931-2253&rft_id=info:doi/10.1002/psb.890&rft_dat=%3Cistex_cross%3Eark_67375_WNG_FX40T6L3_G%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true